Microbot Medical Income Statement (2010-2016) | MBOT

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016
Revenue & cost
Revenue 0.23M0.25M0.70M0.22M0.23M0.22M0.54M0.64M0.25M0.26M0.21M0.06M0.03M0.04M0.04M0.02M0.02M0.08M0.88M0.02M0.03M0.04M0.03M0.02M0.03M0.03M
Cost of Revenue 0.04M0.04M0.06M0.05M0.05M0.06M0.05M0.07M0.06M0.07M0.06M0.07M0.08M0.09M0.09M0.09M0.08M0.06M
Gross Profit 0.19M0.22M0.64M0.17M0.18M0.16M0.49M0.57M0.18M0.19M0.16M0.22M0.20M0.24M0.23M0.25M0.16M0.21M
Operating items
Research & Development 5.04M5.20M5.92M5.53M5.05M4.52M4.83M3.94M3.75M3.48M3.52M4.56M4.80M5.18M4.82M4.63M5.84M4.40M6.64M6.29M7.24M7.72M5.86M5.21M3.69M
Selling, General & Administrative 2.58M2.02M2.49M2.08M2.10M1.73M2.29M1.92M1.78M1.64M2.02M1.89M1.58M1.71M3.65M2.24M2.14M2.07M3.97M2.69M2.06M2.31M2.28M4.63M1.42M1.91M
Other Operating Expenses 0.17M-0.07M0.08M0.11M0.07M0.68M0.04M0.01M0.15M1.41M-0.29M-0.26M-0.27M0.87M313.0017.0010.00-45.000.39M3.80M0.02M
Operating Expenses 7.79M7.22M8.34M7.68M7.27M6.33M7.81M5.90M5.53M5.27M6.95M6.17M6.13M6.63M9.34M6.87M7.98M6.46M10.61M8.98M9.30M10.02M8.53M9.84M8.91M1.91M
Operating Income -7.60M-7.00M-7.71M-7.51M-7.09M-6.16M-7.31M-5.33M-5.35M-5.08M-6.16M-6.26M-6.22M-6.66M-8.96M-6.84M-7.96M-6.38M-9.73M-8.96M-9.27M-9.99M-8.50M-9.81M-8.88M-1.88M
EBIT -7.60M-7.00M-7.71M-7.51M-7.09M-6.16M-7.31M-5.33M-5.35M-5.08M-6.16M-6.26M-6.22M-6.66M-8.96M-6.84M-7.96M-6.38M-9.73M-8.96M-9.27M-9.99M-8.50M-9.81M-8.88M-1.88M
Non-operating items
Interest & Investment Income 594.000.01M0.00M0.00M0.01M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.00M136.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M218.00
Other Non Operating Income 1.52M1.23M-2.18M1.78M3.02M1.70M-6.39M-4.90M6.18M-11.26M4.03M0.03M-0.01M-0.01M2.51M-0.02M-0.02M-0.01M-0.01M0.14M-0.03M0.02M-149.00-0.00M0.24M
Non Operating Income 1.48M1.45M-1.25M1.76M3.06M1.83M0.10M-4.90M6.18M-11.26M4.03M-0.16M0.35M-0.54M2.51M-0.72M-4.01M3.76M-0.38M-0.39M0.81M0.35M-0.46M0.25M11.40M-2.37M
Net income details
EBT -7.63M-7.01M-7.72M-7.53M-7.10M-6.18M-7.33M-5.34M-5.36M-5.09M-6.16M-6.26M-6.61M-7.04M-9.34M-7.22M-8.30M-6.69M-9.99M-9.14M-9.42M-10.09M-8.57M-9.84M-8.88M-1.89M
Profit After Tax -6.12M-5.55M-8.96M-5.75M-4.04M-4.33M-7.21M-10.23M0.83M-16.34M-2.76M-6.27M-5.75M-7.13M-6.85M-7.56M-11.97M-2.62M-10.11M-9.35M-8.46M-9.64M-8.96M-9.56M2.52M-4.25M
Income from Continuing Operations -7.63M-7.01M-7.72M-7.53M-7.10M-6.18M-7.33M-5.34M-5.36M-5.09M-6.16M-6.26M-6.61M-7.04M-9.34M-7.22M-8.30M-6.69M-9.99M-9.14M-9.42M-10.09M-8.57M-9.84M-8.88M-1.89M
Consolidated Net Income -7.63M-7.01M-7.72M-7.53M-7.10M-6.18M-7.33M-5.34M-5.36M-5.09M-6.16M-0.15M-0.12M-0.07M-0.12M-0.06M-0.14M-0.14M-0.11M-9.14M-9.42M-10.09M-8.57M-9.84M-8.88M-1.89M
Income towards Parent Company -7.63M-7.01M-7.72M-7.53M-7.10M-6.18M-7.33M-5.34M-5.36M-5.09M-6.16M-0.15M-0.12M-0.07M-0.12M-0.06M-0.14M-0.14M-0.11M-9.14M-9.42M-10.09M-8.57M-9.84M-8.88M-1.89M
Net Income towards Common Stockholders -7.63M-7.01M-7.72M-7.53M-7.10M-6.18M-7.33M-5.34M-5.36M-5.09M-6.16M-0.15M-0.12M-0.07M-0.12M-0.06M-0.14M-0.14M-0.11M-9.14M-9.42M-10.09M-8.57M-9.84M-8.88M-1.89M
Additional items
EPS (Basic) -0.52-0.44-0.72-0.42-0.29-0.31-0.48-0.450.03-0.54-0.07-0.17-0.15-0.17-0.13-0.14-0.21-0.04-0.15-1.62-1.07-1.07-0.08-0.980.22-0.30
Shares Outstanding (Weighted Average) 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.04M0.04M0.04M0.06M0.07M0.07M0.07M0.09M0.09M
EBITDA -7.60M-7.00M-7.71M-7.51M-7.09M-6.16M-7.31M-5.33M-5.35M-5.08M-6.16M-6.26M-6.22M-6.66M-8.96M-6.84M-7.96M-6.38M-9.73M-8.96M-9.27M-9.99M-8.50M-9.81M-8.88M-1.88M
Interest Expenses 0.03M0.02M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.39M0.38M0.38M0.38M0.34M0.31M0.26M0.19M0.15M0.11M0.07M0.03M128.000.01M